Events

To,    I have reached out to you as your research areas/products/services are related to our upcoming conference. Considering the same, our organizing committee would like to invite to be a part of it and you will be a great fit for our upcoming “World Congress on Advances in Applied Science and Engineering” held during 25-26 March 2026. at London, United Kingdom   The WASE 2026 aims to bring together leading researchers, academicians, industry professionals, and policymakers to share innovations, exchange ideas, and foster collaboration across a wide range of topics. We extend warm invitation to you and your organization to be a part of the conference as a Sponsors/Exhibitor/Speaker/Delegate.   Let me know your interest in the same, accordingly I will share y…

The International Conference on Cardiology and Cardiovascular Science will take place from March 26-28, 2026, in Singapore and online, providing a unique opportunity for medical professionals, academics, and industry leaders to engage in high-level discussions on cardiac health. With sessions in Cardiology Conferences 2026 covering everything from advancements in cardiac electrophysiology to the role of AI in diagnosing cardiovascular diseases, these Cardiology Conferences are set to shape the future of heart disease prevention and treatment. By attending Cardiology Conference, participants will benefit from exposure to the latest research, practical training sessions, and exclusive networking opportunities with top-tier cardiologists and medical innovators. The Cardiovascular Science Conf…

Use coupon COMPLIANCE15 to get 15% discount on this virtual seminar Raw material requirements in a cGMP environment are often overlooked as a Company develops new products. Depending upon the product being developed, e.g., tablets and capsules vs. biotechnology products to include recombinant microorganisms and gene therapy products, as few as fifteen to twenty or as many as sixty raw materials need to be sourced before the process can be moved from initiation through completion. This highly interactive two day seminar on raw material requirements in a cGMP environment will: Compare and Contrast FDA, Health Canada, ICH, USP and EP requirements Review latest updates to include FDA, Health Canada, ICH, USP and EP requirements Examine a variety of the issues surrounding raw materials to incl…

online, 05836, 대한민국

APRIL LIVE WEBINAR Accelerating Skin Disease Drug Discovery Through In Vivo Imaging 🗓️ DATE: April 1, 2026 ⏲️ TIME: 9:00 AM CDT / 10:00 AM EDT / 3:00 PM BST / 4:00 PM CEST 👉 Register HERE IVIM Technology will host a webinar by Dr. Pilhan Kim (KAIST) on recent advances in skin disease research, including atopic dermatitis. The session will explore how intravital microscopy enables real-time imaging in living tissues providing new insights into disease mechanisms and therapeutic responses. Through practical research examples, we will highlight how a…

LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers Squibb/Orbital Therapeutics. Validating LNPs as a stand-out delivery vehicle for cell and gene therapies! Returning to Boston in April 2026, the 5th LNP Formulation and Process Development Summit is an industry-led end-to-end meeting providing the latest scientific content to advance LNP development for a variety of payloads and therapeutic applications, from mRNA vaccines to next-generation cell and gene therapies. This is your one-stop shop to hear insights on LNP discovery, analytics, formulation, process development and large-scale manufacturing. With 3 focused streams, Analytical Development and…

EDUCATION IS OUR TOP PRIORITY!With education documentation becoming a way of life and the budget constraints facing many hospitals and institutions, in conjunction with the Society of Interventional Radiology (SIR) and the Association for Radiologic and Imaging Nursing (ARIN), AVIR strives to build an education program that meets and exceeds the expectations of our attendees. The AVIR Annual Scientific Meeting continues to provide an excellent venue for participation and marketing for our corporate sponsors. AVIR MISSIONis to grow, advance, and continue education in the area of vascular and interventional radiology and to promote professional growth and resources for AVIR members throughout the medical community.The AVIR is comprised of department managers, chief technologists, directors a…

Neuroimmunology is entering a defining moment. With the $470M buyout of Vigil’s TREM2 asset, Ventus’ NLRP3 inhibitor in phase 2a, and promising phase 3 BTKi readouts from Sanofi and Roche, the field is beginning to show encouraging signs of clinical viability in targeting neuroinflammation. Now the real race begins. Uncovering the next wave of mechanisms, biomarkers, and translational strategies that will move beyond today’s successes and unlock new therapeutic frontiers in neurodegeneration and neuroimmune-driven psychiatric disease. The 8th Neuroimmunology Drug Development Summit is the industry’s only meeting fully dedicated to advancing novel neuroinflammatory targets, uniquely bridging cutting-edge academic discovery with the practical lens of drug development. This year’s expanded pr…

Thought Leader Texas is a premier gathering for executives, innovators, and industry leaders who want to stay ahead of fast-moving shifts in business, leadership, and organizational strategy. This summit brings together experts from across sectors to share fresh perspectives, practical insights, and proven approaches that help leaders navigate today’s most pressing challenges. Through keynote talks, panel discussions, and interactive sessions, attendees will explore themes such as leadership development, talent and culture, operational excellence, technology adoption, and long-term strategic growth. Each session is designed to offer actionable takeaways-clear ideas and tools executives can bring back to their organizations. The event also creates space for meaningful networking, allowing l…

Good Manufacturing Practices (GMP) describe the requirements for manufacturing drug product in each country or region and cover areas such as facility design and sanitation, product testing, product identification, equipment, packaging, warehousing and distribution, and recordkeeping. These requirements include the required education, training and experience for employees whose activities affect the quality of drug products. Among those educational requirements are a course in Introductory GMP upon employment at a pharmaceutical company, and annual refresher GMP training. The goal of this seminar is to enable you to: Demonstrate a basic knowledge of GMP requirements Interpret these requirements for your day-to-day operations Avoid the negative consequences of noncompliance Instill a cultu…

Europe's oligonucleotide landscape is entering a pivotal growth phase. With the €21M launch of Aerska and major collaborations such as Novartis and SciNeuron, Lundbeck and Contera, and Secarna and Vect-Horus, European biopharma are rapidly advancing RNA-targeted approaches to address previously undruggable CNS diseases.  In response to this momentum, the inaugural Oligonucleotides for CNS Summit Europe will unite 60+ senior industry leaders for the first European forum dedicated exclusively to CNS-focused Oligonucleotide therapeutics.  The summit delivers three days of highly technical, data-driven discussions addressing the challenges unique to CNS development with insight into next-generation BBB delivery strategies beyond TfR1, advanced in vivo and iPSC models, novel chemistry…

The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models. Attending this premier Marcus Evans conference will enable you to: Establish Effective Governance and Decision-making Process within the Alliance Navigating Data Management from…

The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models. Attending this premier Marcus Evans conference will enable you to: Establish Effective Governance and Decision-making Process within the Alliance Navigating Data Management from…

One foundation. Cross-functional strength. Elevated impact. For years, the question was: What do we build next? More sophisticated AI. More advanced engagement models. Wider access strategies. Each impressive. Each reaching higher. Then market winds shifted. New regulations arrived. Suddenly, the question changed: Can our foundations hold? Walls between functions preventing flexibility. Disconnected data infrastructure fragmenting insights. Inefficiencies becoming liabilities under pressure. Those walls aren't load-bearing, they're removable. That data infrastructure can reinforce decisions. And patient purpose? That's the force binding everything together. You must underpin your customer engagement strategy with reimagined data and infrastructure. You must reprioritise your launch plans t…

The conference features a comprehensive pre-conference focus day dedicated to advancements in device design, followed by a dynamic two-day main conference featuring keynote plenaries, interactive panel discussions, and specialized topic streams covering the most pressing industry challenges and breakthrough solutions including: Device Innovations for Large Volume and Novel Drug Product DeliveryAdvancing Sustainability in the Injectable Device IndustryPrimary Packaging: Ensuring Safe, Stable, and Biocompatible Combination ProductsPatient-Driven Device Design Date and Time: Monday, 27 April 2026 at 08:30 - Wednesday, 29 April 2026 at 17:00

The BPG 2026 will be organised in Blankenberge on April 27-28 for the 2026 edition of the Annual Meeting of the Belgian Polymer Group! The 2026 edition will provide a platform to discuss all current topics in polymer science, engaging both industrial and academic perspectives. The event will also be an opportunity for young Belgian scientists specialising in polymers to present their work through oral communications and posters. The programme will be enriched by invited lectures. At a broader level, the aim of the Belgian Polymer Group (BPG) is to encourage links between the key players in the field of polymer science, both in industry and academia. The BPG also seeks to monitor current research directions being pursued at various universities and industrial R&D laboratories in Belgium…

From transformative genetic therapies in rare diseases to neuroimmunology candidates addressing residual unmet needs in MS, and novel target validation driving confidence in disease modification for neurodegeneration, best- and first-in-class neuroscience opportunities continue to shape and drive pharma investment. Returning for its second year, following the inaugural launch that attracted over 100 attendees, the 2nd Neuroscience Innovation Partnering and Licensing Summit is strategically timed to facilitate multiple high-impact, in-person meetings without the distractions of a broader, less focused setting. Who Attends This Differentiated Business Development Initiative? - Global Pharma: Heads of Business Development, Search and Evaluation, and Asset Scouting for Neuroscience - comparing…

Optimizing ADC Physiochemical, Potency, and Impurity Analytical Methods to Enhance Product Understanding, Quality and Assess DARs for Regulatory Submissions The 5th ADC Analytical Development Summit is the only dedicated platform for tackling the unique analytical complexities of ADC development, bringing together technical leaders to ensure a high-quality, regulatory-compliant ADC product. The ADC landscape is undergoing a rapid transformation with novel modalities like bispecifics, dual payload conjugates, and novel conjugates all push the boundaries of innovation, whilst more traditional ADCs are progressing their way through the pipelines - analytical teams are facing greater challenges in ensuring product quality and regulatory compliance than ever. The 5th ADC Analytical Development…

The GPCR field is experiencing a renaissance, driven by renewed investment, clinical progress, and next-generation technologies unlocking hundreds of previously untargeted receptors. With rapid advances in structural biology, computation, and screening, the race is on to validate new GPCRs, understand dynamic activation mechanisms, and develop assays that better predict therapeutic efficacy and guide smarter candidate selection. Returning as the only industry-led meeting dedicated to GPCR drug discovery, the 5th GPCR-Targeted Drug Discovery Summit features a jam-packed agenda featuring new expert voices, and fresh insights spanning the latest targets, tools, and therapeutic strategies. Join 80+ GPCR-focused leaders across biopharma to share insights, build collaborations, and accelerate ne…

Peptide therapies are rapidly becoming a disruptive modality, led by Merck’s oral PCSK9 inhibitor and Johnson and Johnson’s IL23R, with the hope to develop best-in-class drugs with improved chemistry, formulation and clinical efficacy. To shine a light on the progress of this field, the highly anticipated 3rd Peptide-Based Therapeutics Summit returns to Boston as the industry’s only dedicated platform to turbocharge the next generation of peptide discoveries through development and towards life-saving treatments. Gathering industry leaders including Parabilis Medicines, Circle Pharma, Abbvie, Merck, Chugai Pharmaceuticals and many more, this is your premium forum to explore: - Novel computational tools- Optimize analytical assays- Formulating cell-specific delivery methods- DMPK translatab…

AI is transforming every corner of drug discovery, and biophysics is no exception. From predicting molecular interactions to streamlining data analysis with machine learning, AI is enabling faster, more informed early-stage decisions. Meanwhile, experimental biophysics continues to evolve, with high-resolution and high-throughput platforms expanding the boundaries of what can be measured. Techniques like focal molography, alongside innovations in membrane mimetics and nanodiscs, are providing unprecedented insight into complex targets, including previously intractable membrane proteins. As targets grow more complex and modalities more diverse, the demand for accurate biophysical understanding has never been more essential. From prioritizing hits and defining on-target engagement to optimiz…